Skip to content

Clinical trials

Enrolling by invitation Phase 3 trials in Argentina

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 3 Status: Enrolling by invitation Country / region: Argentina Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20191
20212
20225
20235
20243
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Enrolling by invitation19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen2
Sanofi2
United Therapeutics2
Alkermes, Inc.1
Alnylam Pharmaceuticals1
AstraZeneca1
Celldex Therapeutics1
Eli Lilly and Company1
Ionis Pharmaceuticals, Inc.1
JCR Pharmaceuticals Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Connective Tissue Diseases3
Lupus Erythematosus, Systemic3
Amyloidosis2
Immune System Diseases2
Neoplasms2
Angioedemas, Hereditary1
Asthma1
Autoimmune Diseases1
Breast Neoplasms1
Cardiomyopathies1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.